![Julien Miara](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Julien Miara
Director/Board Member at
SENSORION
Profile
Julien Miara is currently Director at Valerio Therapeutics SA since 2026, Independent Director at Sensorion SA, Director at Versity SA since 2023, and Principal at Invus SAS (Investment Management) since 2018.
Former positions include Director at TopoTarget UK Ltd. and President at Onxeo US.
Education includes a graduate degree from École des Hautes Études Commerciales du Nord, conferred in 2009.
Julien Miara active positions
| Companies | Position | Start |
|---|---|---|
| SENSORION | Director/Board Member | - |
| VALERIO THERAPEUTICS | Director/Board Member | - |
| VERSITY | Director/Board Member | 2023-11-10 |
Invus SAS (Investment Management)
 Invus SAS (Investment Management) Investment ManagersFinance Invus-IM takes significant, long-term positions in public companies whose fundamentals and management they believe in. They focus on stocks that are trading below the firm's assessment of their intrinsic business value. The average holding period in their public equity portfolio is not measured in weeks or months but years. Leveraging their deep expertise in the healthcare sector, Invus-IM also works with their private equity team jointly investing in Series A and Series B rounds of private biotech companies making transformational bets on the future of healthcare, where they continue to support them as they go public. | Analyst-Equity | 2009-12-31 |
Former positions of Julien Miara
| Companies | Position | End |
|---|---|---|
TopoTarget UK Ltd.
 TopoTarget UK Ltd. Drugstore ChainsRetail Trade Develops anti-cancer drugs | Director/Board Member | - |
Onxeo US | President | - |
Training of Julien Miara
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
65
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Valerio Therapeutics SA
 Valerio Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer | Health Technology |
TopoTarget UK Ltd.
TopoTarget UK Ltd. Drugstore ChainsRetail Trade Develops anti-cancer drugs | Retail Trade |
Sensorion SA
 Sensorion SA Pharmaceuticals: MajorHealth Technology Operates as a research and development company that discovers drugs to treat inner ear disorders | Health Technology |
École des Hautes Études Commerciales du Nord
 École des Hautes Études Commerciales du Nord Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Invus SAS (Investment Management)
Invus SAS (Investment Management) Investment ManagersFinance Invus-IM takes significant, long-term positions in public companies whose fundamentals and management they believe in. They focus on stocks that are trading below the firm's assessment of their intrinsic business value. The average holding period in their public equity portfolio is not measured in weeks or months but years. Leveraging their deep expertise in the healthcare sector, Invus-IM also works with their private equity team jointly investing in Series A and Series B rounds of private biotech companies making transformational bets on the future of healthcare, where they continue to support them as they go public. | Finance |
Onxeo US | |
Versity SA
 Versity SA Real Estate DevelopmentFinance Operates an online real estate information platform | Finance |
- Stock Market
- Insiders
- Julien Miara
